American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Broadcom
AVGO
|
+$701M |
| 2 |
Mastercard
MA
|
+$306M |
| 3 |
Estee Lauder
EL
|
+$248M |
| 4 |
IQVIA
IQV
|
+$178M |
| 5 |
Arista Networks
ANET
|
+$163M |
Top Sells
| 1 |
Visa
V
|
+$560M |
| 2 |
Advanced Micro Devices
AMD
|
+$524M |
| 3 |
Apple
AAPL
|
+$439M |
| 4 |
NVIDIA
NVDA
|
+$318M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$261M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Financials | 13.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Healthcare | 10.02% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Valhi
VHI
$458M
| $477K | ﹤0.01% |
20,386
+6,117
| +43% | +$143K |
|
2502
M-tron Industries
MPTI
$139M
| $474K | ﹤0.01% |
+9,797
| New | +$474K |
|
2503
Perma-Pipe International
PPIH
$247M
| $474K | ﹤0.01% |
+31,702
| New | +$474K |
|
2504
Tourmaline Bio
TRML
$1.22B
| $474K | ﹤0.01% |
+23,357
| New | +$474K |
|
|
CRGX
2505
DELISTED
CARGO Therapeutics
CRGX
| $474K | ﹤0.01% |
+32,846
| New | +$474K |
|
2506
Veracyte
VCYT
$2.43B
| $471K | ﹤0.01% |
11,885
+4,761
| +67% | +$189K |
|
2507
Park Aerospace
PKE
$372M
| $471K | ﹤0.01% |
32,117
-36,654
| -53% | -$537K |
|
|
XHR
2508
Xenia Hotels & Resorts
XHR
$1.41B
| $470K | ﹤0.01% |
+31,612
| New | +$470K |
|
2509
Pyxis Oncology
PYXS
$113M
| $468K | ﹤0.01% |
299,937
+140,498
| +88% | +$219K |
|
|
SRTA
2510
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$351M
| $467K | ﹤0.01% |
109,948
+10,726
| +11% | +$45.6K |
|
2511
Enphase Energy
ENPH
$4.92B
| $461K | ﹤0.01% |
6,710
-624,978
| -99% | -$42.9M |
|
2512
Krispy Kreme
DNUT
$541M
| $459K | ﹤0.01% |
46,195
-9,810
| -18% | -$97.4K |
|
2513
Cimpress
CMPR
$1.4B
| $458K | ﹤0.01% |
6,382
+1,086
| +21% | +$77.9K |
|
2514
Brown & Brown
BRO
$30.9B
| $456K | ﹤0.01% |
4,469
-9,398
| -68% | -$959K |
|
2515
Fonar
FONR
$98.8M
| $455K | ﹤0.01% |
30,047
| – | – |
|
2516
Patria Investments
PAX
$2.31B
| $455K | ﹤0.01% |
39,088
+13,400
| +52% | +$156K |
|
2517
Ouster
OUST
$1.67B
| $452K | ﹤0.01% |
37,007
-28,393
| -43% | -$347K |
|
2518
Vivid Seats
SEAT
$110M
| $446K | ﹤0.01% |
4,820
+423
| +10% | +$39.2K |
|
2519
Chart Industries
GTLS
$8.95B
| $438K | ﹤0.01% |
2,296
-1,725
| -43% | -$329K |
|
2520
Freshworks
FRSH
$3.63B
| $437K | ﹤0.01% |
27,007
+2
| +0% | +$32 |
|
2521
eHealth
EHTH
$122M
| $436K | ﹤0.01% |
46,422
+1,772
| +4% | +$16.7K |
|
2522
Crawford & Co Class B
CRD.B
$494M
| $430K | ﹤0.01% |
36,963
-526
| -1% | -$6.12K |
|
2523
NB Bancorp
NBBK
$737M
| $430K | ﹤0.01% |
23,794
+9,612
| +68% | +$174K |
|
|
ALEX
2524
Alexander & Baldwin
ALEX
$1.34B
| $429K | ﹤0.01% |
24,188
+797
| +3% | +$14.1K |
|
2525
Farmers & Merchants Bancorp
FMAO
$357M
| $428K | ﹤0.01% |
14,529
+122
| +0.8% | +$3.59K |
|